These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38427928)

  • 1. Effects of the COVID-19 Pandemic on ART Initiation and Access to HIV Viral Load Monitoring in Adults Living With HIV in West Africa: A Regression Discontinuity Analysis.
    Ben Farhat J; Tiendrebeogo T; Malateste K; Poda A; Minga A; Messou E; Chenal H; Ezechi O; Ofotokun I; Ekouevi DK; Bonnet F; Barger D; Jaquet A;
    J Acquir Immune Defic Syndr; 2024 Jun; 96(2):114-120. PubMed ID: 38427928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.
    Dahourou DL; Amorissani-Folquet M; Malateste K; Amani-Bosse C; Coulibaly M; Seguin-Devaux C; Toni T; Ouédraogo R; Blanche S; Yonaba C; Eboua F; Lepage P; Avit D; Ouédraogo S; Van de Perre P; N'Gbeche S; Kalmogho A; Salamon R; Meda N; Timité-Konan M; Leroy V;
    BMC Med; 2017 Apr; 15(1):85. PubMed ID: 28434406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa.
    Coffie PA; Tchounga BK; Bado G; Kabran M; Minta DK; Wandeler G; Gottlieb GS; Dabis F; Eholie SP; Ekouevi DK
    BMC Infect Dis; 2017 Jul; 17(1):466. PubMed ID: 28676076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in dolutegravir utilisation in children, adolescents and young adults (0-24 years) living with HIV: An analysis of the IeDEA Paediatric West African cohort.
    Desmonde S; Dame J; Malateste K; David A; Amorissani-Folquet M; N'Gbeche S; Sylla M; Takassi E; Eboua FT; Kouakou K; Tossa LB; Yonaba C; Leroy V;
    medRxiv; 2024 Nov; ():. PubMed ID: 38826257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.
    Amani-Bosse C; Dahourou DL; Malateste K; Amorissani-Folquet M; Coulibaly M; Dattez S; Emieme A; Barry M; Rouzioux C; N'gbeche S; Yonaba C; Timité-Konan M; Mea V; Ouédraogo S; Blanche S; Meda N; Seguin-Devaux C; Leroy V
    J Int AIDS Soc; 2017 Apr; 20(1):21362. PubMed ID: 28453240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding integrated HPV testing and treatment of pre-cancerous cervical cancer in Burkina Faso, Cote d'Ivoire, Guatemala and Philippines: study protocol.
    Kabue M; Gauvreau CL; Daceney N; Bertram MM; Shissler T; Reis V; Dodo M; Garces A; Llave C; Dao B; Mohan D; Huang L
    Reprod Health; 2023 Nov; 20(1):167. PubMed ID: 37957689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.
    Seyler C; Anglaret X; Dakoury-Dogbo N; Messou E; Touré S; Danel C; Diakité N; Daudié A; Inwoley A; Maurice C; Tonwe-Gold B; Rouet F; N'Dri-Yoman T; Salamon R;
    Antivir Ther; 2003 Oct; 8(5):385-93. PubMed ID: 14640385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d'Ivoire West Africa.
    Tchounga BK; Charpentier C; Coffie PA; Dabis F; Descamps D; Eholie SP; Ekouevi DK
    PLoS One; 2020; 15(8):e0236642. PubMed ID: 32756581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intersection of reproductive coercion and intimate partner violence: cross-sectional influences on women's contraceptive use in Burkina Faso, Côte d'Ivoire and Kenya.
    Wood SN; Thomas HL; Thiongo M; Guiella G; Bazié F; Onadja Y; Mosso R; Fassassi R; Gichangi P; Decker MR
    BMJ Open; 2023 May; 13(5):e065697. PubMed ID: 37164455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.
    Ekouevi DK; Balestre E; Coffie PA; Minta D; Messou E; Sawadogo A; Minga A; Sow PS; Bissagnene E; Eholie SP; Gottlieb GS; Dabis F; ; Zannou DM; Ahouada C; Akakpo J; Ahomadegbé C; Bashi J; Gougounon-Houéto A; Azon-Kouanou A; Houngbé F; Koumakpaï S; Alihonou F; d'Almeida M; Hodonou I; Hounhoui G; Sagbo G; Tossa-Bagnan L; Adjide H; Drabo J; Bognounou R; Dienderé A; Traore E; Zoungrana L; Zerbo B; Sawadogo AB; Zoungrana J; Héma A; Soré I; Bado G; Tapsoba A; Yé D; Kouéta F; Ouedraogo S; Ouédraogo R; Hiembo W; Gansonré M; Messou E; Gnokoro JC; Koné M; Kouakou GM; Bosse CA; Brou K; Assi AI; Chenal H; Hawerlander D; Soppi F; Minga A; Abo Y; Bomisso G; Eholié SP; Amego MD; Andavi V; Diallo Z; Ello F; Tanon AK; Koule SO; Anzan KC; Guehi C; Aka EA; Issouf KL; Kouakou JC; N'gbeche MS; Touré P; Avit-Edi D; Kouakou K; Moh M; Yao VA; Folquet MA; Dainguy ME; Kouakou C; Méa-Assande VT; Oka-Berete G; Zobo N; Acquah P; Kokora MB; Eboua TF; Timité-Konan M; Ahoussou LD; Assouan JK; Sami MF; Kouadio C; Renner L; Goka B; Welbeck J; Sackey A; Owiafe SN; Wejse C; Silva ZJ; Paulo J; Rodrigues A; da Silva D; Medina C; Oliviera-Souto I; Ostergaard L; Laursen A; Sodemann M; Aaby P; Fomsgaard A; Erikstrup C; Eugen-Olsen J; Maïga MY; Diakité FF; Kalle A; Katile D; Traore HA; Minta D; Cissé T; Dembelé M; Doumbia M; Fomba M; Kaya AS; Traoré AM; Traoré H; Toure AA; Dicko F; Sylla M; Berthé A; Traoré HC; Koïta A; Koné N; N'diaye C; Coulibaly ST; Traoré M; Traoré N; Charurat M; Ajayi S; Dapiap S; Otu ; Igbinoba F; Benson O; Adebamowo C; James J; Obaseki ; Osakede P; Olasode J; Sow PS; Diop B; Manga NM; Tine JM; Signate Sy H; Ba A; Diagne A; Dior H; Faye M; Gueye RD; Mbaye AD; Patassi A; Kotosso A; Kariyare BG; Gbadamassi G; Komi A; Mensah-Zukong KE; Pakpame P; Lawson-Evi AK; Atakouma Y; Takassi E; Djeha A; Ephoévi-Gah A; Djibril Sel-H; Dabis F; Bissagnene E; Arrivé E; Coffie P; Ekouevi D; Jaquet A; Leroy V; Lewden C; Sasco A; Azani JC; Allou G; Balestre E; Bohossou F; Karcher S; Gonsan JM; Carrou JL; Lenaud S; Nchot C; Malateste K; Yao AR; Siloué B; Clouet G; Djetouan H; Doring A; Kouakou A; Rabourdin E; Rivenc J; Anglaret X; Ba B; Essanin JB; Ciaranello A; Datté S; Desmonde S; Diby JS; Gottlieb GS; Horo AG; Kangah SN; Malvy D; Meless D; Mounkaila-Harouna A; Ndondoki C; Shiboski C; Thiébaut R; Pac-Ci ; Abidjan
    PLoS One; 2013; 8(6):e66135. PubMed ID: 23824279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Patterns of Use and Acceptability of Mobile Phones Among People Living With HIV to Improve Care and Treatment: Cross-Sectional Study in Three Francophone West African Countries.
    Lepère P; Touré Y; Bitty-Anderson AM; Boni SP; Anago G; Tchounga B; Touré P; Minga A; Messou E; Kanga G; Koule S; Poda A; Calmy A; Ekouevi DK; Coffie PA
    JMIR Mhealth Uhealth; 2019 Nov; 7(11):e13741. PubMed ID: 31719023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies.
    Ouattara EN; Robine M; Eholié SP; MacLean RL; Moh R; Losina E; Gabillard D; Paltiel AD; Danel C; Walensky RP; Anglaret X; Freedberg KA
    Clin Infect Dis; 2016 Jun; 62(11):1454-1462. PubMed ID: 26936666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subregional origins of emerging SARS-CoV-2 variants during the second pandemic wave in Côte d'Ivoire.
    Anoh EA; Wayoro O; Monemo P; Belarbi E; Sachse A; Wilkinson E; San JE; Leendertz FH; Diané B; Calvignac-Spencer S; Akoua-Koffi C; Schubert G
    Virus Genes; 2023 Jun; 59(3):370-376. PubMed ID: 36932280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing rate of TAMs and etravirine resistance in HIV-1-infected adults between 12 and 24 months of treatment: the VOLTART cohort study in Côte d'Ivoire, West Africa.
    Messou E; Chaix ML; Gabillard D; Yapo V; Toni TD; Minga A; Kouakou MG; Ouattara E; Rouzioux C; Danel C; Eholie SP; Anglaret X
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):211-9. PubMed ID: 23797690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.
    Messou E; Chaix ML; Gabillard D; Minga A; Losina E; Yapo V; Kouakou M; Danel C; Sloan C; Rouzioux C; Freedberg KA; Anglaret X
    J Acquir Immune Defic Syndr; 2011 Apr; 56(4):356-64. PubMed ID: 21191309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis.
    Dorward J; Khubone T; Gate K; Ngobese H; Sookrajh Y; Mkhize S; Jeewa A; Bottomley C; Lewis L; Baisley K; Butler CC; Gxagxisa N; Garrett N
    Lancet HIV; 2021 Mar; 8(3):e158-e165. PubMed ID: 33549166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa.
    Ndondoki C; Dicko F; Ahuatchi Coffie P; Kassi Eboua T; Ekouevi DK; Kouadio K; Edmond Aka A; Malateste K; Dabis F; Amani-Bosse C; Toure P; Leroy V;
    J Int AIDS Soc; 2014; 17(1):18737. PubMed ID: 24894377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the COVID-19 pandemic on HIV service delivery and viral suppression: Findings from the SHARP program in Northern Nigeria.
    Mugo C; Adedokun O; Alo OD; Ezeokafor N; Adeyemi S; Kpamor Z; Madueke L; James E; Adebajo SB; Semo BW
    PLoS One; 2024; 19(4):e0300335. PubMed ID: 38564514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study.
    Ayouba A; Lien TT; Nouhin J; Vergne L; Aghokeng AF; Ngo-Giang-Huong N; Diop H; Kane CT; Valéa D; Rouet F; Joulia-Ekaza D; Toni TD; Nerrienet E; Ngole EM; Delaporte E; Costagliola D; Peeters M; Chaix ML
    AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1193-6. PubMed ID: 19886834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential population-level effects of HIV self-test distribution among key populations in Côte d'Ivoire, Mali, and Senegal: a mathematical modelling analysis.
    Silhol R; Maheu-Giroux M; Soni N; Simo Fotso A; Rouveau N; Vautier A; Doumenc-Aïdara C; Geoffroy O; N'Guessan KN; Sidibé Y; Kabemba OK; Gueye PA; Ndeye PD; Mukandavire C; Vickerman P; Keita A; Ndour CT; Larmarange J; Boily MC;
    Lancet HIV; 2024 Aug; 11(8):e531-e541. PubMed ID: 38991596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.